What does CTII mean in NASDAQ SYMBOLS
CTII stands for Cell Technology International, Inc. It is a biotechnology company that specializes in the development, manufacturing, and marketing of cell-based therapies and products for the treatment of a range of diseases and conditions.
CTII meaning in NASDAQ Symbols in Business
CTII mostly used in an acronym NASDAQ Symbols in Category Business that means Cell Technology International, Inc.
Shorthand: CTII,
Full Form: Cell Technology International, Inc.
For more information of "Cell Technology International, Inc.", see the section below.
CTII Meaning in Business
CTII plays a significant role in the healthcare industry by providing innovative cell-based solutions that address unmet medical needs. The company's focus on cell technology has led to the development of promising treatments for conditions such as cancer, autoimmune diseases, and regenerative medicine.
CTII Full Form
The full form of CTII is Cell Technology International, Inc.. The company was founded in 1997 and is headquartered in Mountain View, California. CTII has a global presence with operations in the United States, Europe, and Asia.
What Does CTII Stand for
CTII stands for Cell Technology International, Inc. and represents the company's commitment to advancing cell technology for the benefit of patients and the healthcare industry.
Essential Questions and Answers on Cell Technology International, Inc. in "BUSINESS»NASDAQ"
What is CTII?
Cell Technology International, Inc. (CTII) is a biotechnology company focused on developing and commercializing cell-based therapies for the treatment of cancer and other diseases.
What is CTII's main focus?
CTII's primary focus is the development of Chimeric Antigen Receptor (CAR) T-cell therapies, which involve genetically modifying a patient's own immune cells to target and destroy cancer cells.
What is CTII's most advanced product candidate?
CTII's most advanced product candidate is CTI002, a CAR T-cell therapy targeting the CD19 antigen on B-cell leukemias and lymphomas.
What is the current stage of development for CTI002?
CTI002 is currently in Phase 2 clinical trials for the treatment of relapsed/refractory acute lymphoblastic leukemia (ALL).
What are the expected benefits of CTI002?
CTI002 has shown promising results in clinical trials, including high rates of complete remission in patients with relapsed/refractory ALL.
Final Words: CTII is a leading biotechnology company that is driving innovation in the field of cell-based therapies. The company's focus on research and development has resulted in the development of promising treatments for a range of diseases and conditions. CTII is well-positioned to continue its growth and contribute to the advancement of healthcare in the years to come.
CTII also stands for: |
|
| All stands for CTII |